Signal active
Organization
Contact Information
Overview
PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and helped lead the world's largest open-science drug discovery effort; COVID Moonshot.
About
Biotechnology, Artificial Intelligence (AI), Machine Learning, Pharmaceutical, Therapeutics
2019
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
PostEra headquartered in United States, North America, operates in the Biotechnology, Artificial Intelligence (AI), Machine Learning, Pharmaceutical, Therapeutics sector. The company focuses on Biotechnology and has secured $2.1B in funding across 80 round(s). With a team of 11-50 employees, PostEra is actively contributing to advancements in Biotechnology. Their latest funding round, Grant - PostEra, raised $Unknown amount. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
4
1
0
$26.4M
Details
3
PostEra has raised a total of $26.4M in funding over 3 rounds.
Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
---|---|---|---|---|
2020 | Seed | 150.0K | ||
2020 | Seed | 2.3M | ||
2022 | Early Stage Venture | 24.0M |
Investors
PostEra is funded by 19 investors.
Investor Name | Lead Investor | Funding Round | Partners |
---|---|---|---|
PostEra | - | FUNDING ROUND - PostEra | 24.0M |
HOF Capital | - | FUNDING ROUND - HOF Capital | 24.0M |
PostEra | - | FUNDING ROUND - PostEra | undefined |
National Institutes of Health | - | FUNDING ROUND - National Institutes of Health | undefined |
Recent Activity
There is no recent news or activity for this profile.